Highlights HCW Biologics Inc.

Equities

HCWB

US40423R1059

Delayed Nasdaq Other stock markets 17:03:04 21/05/2024 BST			5-day change	1st Jan Change
1.102 ^USD	-0.72%		-4.17%	-10.04%

05-16	HCW Biologics Inc. announced that it expects to receive $10 million in funding	CI
04-01	HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
HCW Biologics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	04-01	CI
HCW Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q3 Revenue $853,102	11-14	MT
HCW Biologics Inc. Announces Results from Preliminary Human Data Readout from an Ongoing Phase 1 Clinical Trial Sponsored by the University of Minnesota	11-08	CI
HCW Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23	CI
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q2 Revenue $622,807	11/08/23	MT
HCW Biologics Says It Received Patent for Methods to Treat Diseases Caused by Chronic Inflammation	14/06/23	MT
HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	09/05/23	CI
HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	28/03/23	AQ
HCW Biologics Inc. Enters Cooperative Research and Development Agreement with National Cancer Institute	08/12/22	CI
HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	07/11/22	AQ
HCW Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	07/11/22	CI
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q3 Revenue $361.8M	07/11/22	MT
HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights	07/11/22	AQ
HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	12/08/22	AQ
HCW Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22	CI
HCW Biologics : Reports Second Quarter 2022 Financial Results And Recent Business Highlights - Form 8-K	12/08/22	PU
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q2 Revenue $166,800	12/08/22	MT
HCW Biologics Reports Second Quarter 2022 Financial Results And Recent Business Highlights	12/08/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights HCW Biologics Inc.

Equities

HCWB

US40423R1059

Highlights

Filters